These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 10604951)

  • 21. Pharmacology of delta2 glutamate receptors: effects of pentamidine and protons.
    Williams K; Dattilo M; Sabado TN; Kashiwagi K; Igarashi K
    J Pharmacol Exp Ther; 2003 May; 305(2):740-8. PubMed ID: 12606689
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Excitotoxic death induced by released glutamate in depolarized primary cultures of mouse cerebellar granule cells is dependent on GABAA receptors and niflumic acid-sensitive chloride channels.
    Babot Z; Cristòfol R; Suñol C
    Eur J Neurosci; 2005 Jan; 21(1):103-12. PubMed ID: 15654847
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Competitive inhibition at the glycine site of the N-methyl-D-aspartate receptor by the anesthetics xenon and isoflurane: evidence from molecular modeling and electrophysiology.
    Dickinson R; Peterson BK; Banks P; Simillis C; Martin JC; Valenzuela CA; Maze M; Franks NP
    Anesthesiology; 2007 Nov; 107(5):756-67. PubMed ID: 18073551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel antagonists of the inhibitory glycine receptor derived from quinolinic acid compounds.
    Schmieden V; Jezequel S; Betz H
    Mol Pharmacol; 1996 Nov; 50(5):1200-6. PubMed ID: 8913351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural features of the glutamate binding site in recombinant NR1/NR2A N-methyl-D-aspartate receptors determined by site-directed mutagenesis and molecular modeling.
    Chen PE; Geballe MT; Stansfeld PJ; Johnston AR; Yuan H; Jacob AL; Snyder JP; Traynelis SF; Wyllie DJ
    Mol Pharmacol; 2005 May; 67(5):1470-84. PubMed ID: 15703381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure-activity relationships of 4-hydroxy-3-nitroquinolin-2(1H)-ones as novel antagonists at the glycine site of N-methyl-D-aspartate receptors.
    Cai SX; Zhou ZL; Huang JC; Whittemore ER; Egbuwoku ZO; Hawkinson JE; Woodward RM; Weber E; Keana JF
    J Med Chem; 1996 Nov; 39(23):4682-6. PubMed ID: 8917657
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of plasma protein binding on in vivo activity and brain penetration of glycine/NMDA receptor antagonists.
    Rowley M; Kulagowski JJ; Watt AP; Rathbone D; Stevenson GI; Carling RW; Baker R; Marshall GR; Kemp JA; Foster AC; Grimwood S; Hargreaves R; Hurley C; Saywell KL; Tricklebank MD; Leeson PD
    J Med Chem; 1997 Dec; 40(25):4053-68. PubMed ID: 9406596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ethanol, sedative hypnotics and glutamate receptor function in brain and cultured cells.
    Hoffman PL; Tabakoff B
    Alcohol Alcohol Suppl; 1993; 2():345-51. PubMed ID: 7748322
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glutamate receptor ligands as anxiolytics.
    Chojnacka-Wójcik E; Kłodzinska A; Pilc A
    Curr Opin Investig Drugs; 2001 Aug; 2(8):1112-9. PubMed ID: 11892923
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ethanol inhibition of NMDA receptor function in primary cultures of rat cerebellar granule cells and cerebral cortical cells.
    Hoffman PL; Snell LD; Bhave SV; Tabakoff B
    Alcohol Alcohol Suppl; 1994; 2():199-204. PubMed ID: 8974336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design of antagonists for NMDA and AMPA receptors.
    Bolshakov KV; Kim KH; Potapjeva NN; Gmiro VE; Tikhonov DB; Usherwood PN; Mellor IR; Magazanik LG
    Neuropharmacology; 2005 Aug; 49(2):144-55. PubMed ID: 15996563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of trifluoroperazine isolates a [(3)H]Ifenprodil binding site in rat brain membranes with the pharmacology of the voltage-independent ifenprodil site on N-methyl-D-aspartate receptors containing NR2B subunits.
    Coughenour LL; Barr BM
    J Pharmacol Exp Ther; 2001 Jan; 296(1):150-9. PubMed ID: 11123375
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potentiation of the NMDA receptor-mediated responses through the activation of the glycine site by microglia secreting soluble factors.
    Hayashi Y; Ishibashi H; Hashimoto K; Nakanishi H
    Glia; 2006 Apr; 53(6):660-8. PubMed ID: 16498631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peripherally acting NMDA receptor/glycineB site receptor antagonists inhibit morphine tolerance.
    Danysz W; Kozela E; Parsons CG; Sladek M; Bauer T; Popik P
    Neuropharmacology; 2005 Mar; 48(3):360-71. PubMed ID: 15721168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Model structures of the N-methyl-D-aspartate receptor subunit NR1 explain the molecular recognition of agonist and antagonist ligands.
    Moretti L; Pentikäinen OT; Settimo L; Johnson MS
    J Struct Biol; 2004 Mar; 145(3):205-15. PubMed ID: 14960371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tricyclic heteroaromatic systems. 3-substituted 1,2,3,5,6,7-hexahydro-2,5,6-trioxopyrazino[1,2,3-de]-quinoxalines as novel antagonists at the glycine-NMDA site.
    Varano F; Catarzi D; Colotta V; Cecchi L; Filacchioni G; Galli A; Costagli C
    Farmaco; 1997 Mar; 52(3):179-82. PubMed ID: 9212452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Putative NMDA receptors in Hydra: a biochemical and functional study.
    Pierobon P; Sogliano C; Minei R; Tino A; Porcu P; Marino G; Tortiglione C; Concas A
    Eur J Neurosci; 2004 Nov; 20(10):2598-604. PubMed ID: 15548203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Excitatory glycine receptors containing the NR3 family of NMDA receptor subunits.
    Chatterton JE; Awobuluyi M; Premkumar LS; Takahashi H; Talantova M; Shin Y; Cui J; Tu S; Sevarino KA; Nakanishi N; Tong G; Lipton SA; Zhang D
    Nature; 2002 Feb; 415(6873):793-8. PubMed ID: 11823786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis of thieno[2,3-b]pyridinones acting as cytoprotectants and as inhibitors of [3H]glycine binding to the N-methyl-D-aspartate (NMDA) receptor.
    Buchstaller HP; Siebert CD; Steinmetz R; Frank I; Berger ML; Gottschlich R; Leibrock J; Krug M; Steinhilber D; Noe CR
    J Med Chem; 2006 Feb; 49(3):864-71. PubMed ID: 16451052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional in vitro characterization of CR 3394: a novel voltage dependent N-methyl-D-aspartate (NMDA) receptor antagonist.
    Losi G; Lanza M; Makovec F; Artusi R; Caselli G; Puia G
    Neuropharmacology; 2006 Mar; 50(3):277-85. PubMed ID: 16236334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.